THREAD --> In this time of #COVID19, I figured it might be handy to share some basics with other reporters who might be new to the health beat. What's an 'antibody'? What is 'viral load'? Here's a list of some things reporters might want to know. I'm adding to it slowly.
First off. A lot of the tests being discussed are looking for 'antibodies'. What the heck are those? In a nutshell, proteins made by certain immune cells that bind to particles in the body (usually foreign) that we call 'antigens'. Here's a 3:28min primer:
What's that? You're a reporter too busy to watch a 3:28min video? I understand. Here's a picture capturing pretty much the same thing 3/n (source: https://slideplayer.com/slide/9390892/ )
So, about that whole thing regarding whether viruses can 'live' on surfaces? Turns out that viruses aren't really 'alive' unless they can access cells to replicate. They're just a string of RNA or DNA letters. They need a cell's machinery to replicate. 4/n https://www.scientificamerican.com/article/are-viruses-alive-2004/
Long story short: viruses need to get into cells, and hijack the protein-making factories inside cells. When scientists detect traces of viral DNA or RNA on surfaces, they have to grow it inside cells to see if it's still really infectious. 5/n
Next: 'viral load'. I suspect we'll be hearing about this more. I'll go with Google's definition of this one: Viral load is "a measurement of the amount of a virus in an organism, typically in the bloodstream, usually stated in virus particles per milliliter." 6/n
Here's a good little video on how vaccines work. It's basic *and it does not cover all vaccine platforms*, but it's a good starting point. 2:27min, but skip to 1:45min if you are on deadline:
Also, not all vaccines work the same way! There are different 'platforms' of vaccines (Live-attenuated, inactivated, subunit, etc). Thankfully, the U.S. government has this handy FAQ sheet on different vaccine technologies. 8/n https://www.vaccines.gov/basics/types 
I LOVE pictures! I don't think reporters look at images of viruses enough. Here's a handy one of #SARSCoV2 from @TheEconomist. 9/n https://www.economist.com/briefing/2020/03/12/understanding-sars-cov-2-and-the-drugs-that-might-lessen-its-power
Now for... clinical trials!! If you are wondering what a 'phase 1' trial is vs a 'phase 3' trial, here's a handy guide from the American Cancer Society. It's for cancer trials, not for infectious diseases, but you can get the idea. 11/n https://www.cancer.org/treatment/treatments-and-side-effects/clinical-trials/what-you-need-to-know/phases-of-clinical-trials.html
If you are too on deadline to read that last link, here's a quick-and-dirty distillation:
1. phase 1 = few people, assessing *safety*
2. phase 2 = more people, glimpse at response + side effects
3. phase 3 = often multiple trial sites, large scale, looking for efficacy, too
12/n
Drug approval! It's not as simple as some --errrr politicians -- make it seem. Here's a neat little chart your tax dollars paid for. Enjoy it! It's useful! 13/n https://www.fda.gov/drugs/drug-information-consumers/fdas-drug-review-process-continued
Here's a cheat sheet on key drug approval terms:
Preclinical: tests in cells, animals
IND: investigational new drug (application) = what drugmakers submit when they want to start a clinical trial
NDA: new drug application = what they submit to get approval to market a drug

14/n
Here's a cool illustration from industry, h/t @VijaySciWri - but take with a giant grain of salt. It's not a sure bet by any means that vaccines will be on this timeline. 15/n
Another neat picture to add to this thread! Via @Laurie_Garrett. It shows how 805 #SARCoV2 #coronaviruses sequences relate to each other. (Note that "clades" of viruses descend from common ancestors). 16/n
You can follow @rkhamsi.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: